Jonathan Krant
Rheumatology · Peterborough, NHNPI 1023165172
Payments from drug & device makers
Across 825 payments — averaging $585.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$358K
- Amgen$64K
- Novartis$38K
- Eli Lilly$10K
- Boehringer Ingelheim International GmbH$4K
- Vertex$2K
- plus $7K from 26 others
Across 2 payments — averaging $7891.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$16K
What the payments were for
- Consulting fees$26,7268%
- Speaking & faculty fees$257,67079%
- Travel & lodging$27,9849%
- Food & beverage$15,2345%
- Education$2040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 316 | $358,028 |
| Amgen(2 entities) | 185 | $63,735 |
| Novartis | 108 | $38,253 |
| Eli Lilly | 5 | $9,931 |
| Boehringer Ingelheim International GmbH | 2 | $3,997 |
| Vertex | 5 | $2,225 |
| Johnson & Johnson | 40 | $1,210 |
| UCB, Inc. | 46 | $1,037 |
| Tersera Therapeutics LLC | 1 | $580 |
| Dr.reddy's Laboratories,inc. | 1 | $580 |
| ZOLL Medical Corporation | 1 | $450 |
| E.r. Squibb & Sons, L.L.C. | 7 | $386 |
| Pfizer | 20 | $378 |
| Aurinia Pharma U.S., Inc. | 12 | $251 |
| Janssen Scientific Affairs, LLC | 3 | $222 |
| Genentech USA, Inc. | 6 | $168 |
| ANI Pharmaceuticals, Inc. | 8 | $167 |
| AstraZeneca | 8 | $162 |
| Boehringer Ingelheim | 3 | $161 |
| Lilly USA, LLC | 11 | $160 |
| GSK | 9 | $155 |
| Bristol Myers Squibb | 5 | $139 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $111 |
| Cardinal Health 110 LLC | 1 | $100 |
| Actelion Pharmaceuticals US, Inc. | 3 | $84 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $61 |
| Radius Health, Inc. | 4 | $58 |
| Endo Pharmaceuticals Inc. | 4 | $52 |
| Organon | 1 | $36 |
| Invivyd Inc | 1 | $21 |
| Bioventus LLC | 1 | $15 |
| Sobi, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$482,926 in reported general payments places this provider in the 95th percentile of 48 rheumatology providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $105,099 |
| Orencia ClickjectAbatacept | 17 | $101,345 |
| BenlystaBelimumab | 11 | $52,373 |
| Methylprednisolone | 54 | $1,129 |
| Hydroxychloroquine Sulfate | 30 | $944 |
| Pregabalin | 29 | $369 |
| Duloxetine Hcl | 24 | $294 |
| Prednisone | 55 | $287 |
| MethotrexateMethotrexate Sodium | 20 | $233 |
| Gabapentin | 14 | $148 |
| Naproxen | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBenlysta | $155 | $52,37311 claims |
| Dr.reddy's Laboratories,inc.Pregabalin | $580 | $36929 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 48 rheumatology providers in New Hampshire.
Other rheumatology in Peterborough
- William RigbyLebanon$4.1M
- John GormanNashua$135K
- Robert SimmsLebanon$102K
- Naureen MirzaManchester$67K
- Christopher BurnsLebanon$59K
- Kalyani GovindarajuNashua$27K
- Todd DaughertyHenniker$22K
- Stephanie MathewLebanon$10K
- Yan LiConcord$4K
- Jenny LinManchester$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.